SEL24-B489
Modify Date: 2025-11-29 21:56:30
SEL24-B489 structure
|
Common Name | SEL24-B489 | ||
|---|---|---|---|---|
| CAS Number | 1616359-00-2 | Molecular Weight | 446.143 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C15H18Br2N4O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of SEL24-B489SEL24-B489 (SEL24) is a potent, dual PIM and FLT3-ITD inhibitor with Kd of 2/2/3 nM for PIM1/2/3, Kd of 160/16 nM for FLT3-WT/FLT3-ITD, respectively; exhibits significantly broader on-target activity in AML cell lines (MV-4-11 GI50=20 nM) and primary AML blasts than selective FLT3-ITD or PIM inhibitors, decreases viability of AML cells with FLT3-TKD mutations associated with resistance to selective FLT3-ITD inhibitors; inhibits the growth of a broad panel of AML cell lines in xenograft models. Blood Cancer Phase 2 Clinical |
| Name | SEL24-B489 |
|---|
| Description | SEL24-B489 (SEL24) is a potent, dual PIM and FLT3-ITD inhibitor with Kd of 2/2/3 nM for PIM1/2/3, Kd of 160/16 nM for FLT3-WT/FLT3-ITD, respectively; exhibits significantly broader on-target activity in AML cell lines (MV-4-11 GI50=20 nM) and primary AML blasts than selective FLT3-ITD or PIM inhibitors, decreases viability of AML cells with FLT3-TKD mutations associated with resistance to selective FLT3-ITD inhibitors; inhibits the growth of a broad panel of AML cell lines in xenograft models. Blood Cancer Phase 2 Clinical |
|---|---|
| References | References 1. Czardybon W, et al. Oncotarget. 2018 Mar 30;9(24):16917-16931. 2. Białopiotrowicz E, et al. J Cell Mol Med. 2018 Apr 17. doi: 10.1111/jcmm.13632. 3. Szydłowski M, et al. Blood. 2017 Sep 21;130(12):1418-1429. View Related Products by Target Pim Blood Cancer |
| Molecular Formula | C15H18Br2N4O2 |
|---|---|
| Molecular Weight | 446.143 |
| InChIKey | UOUBCIJIWDLRGM-UHFFFAOYSA-N |
| SMILES | CC(C)n1c(C2CCNCC2)nc2c([N+](=O)[O-])c(Br)c(Br)cc21 |